Medical Cannabis in Bermuda: New Regulations, Patient Access, and Legal Developments

Access to cannabis treatment has become a key healthcare policy concern around the world. Bermuda is also making efforts to set up a regulatory framework for the provision of such treatment to those patients who would benefit from such medicines under qualified medical supervision.

The government’s latest statements clearly signal that there will be a regulated system that will place patients’ interests first along with prescription regulations, high-quality products, and safety measures. However, it needs to go through the process of legislation before the new system becomes a reality.

Thus, the success of medical cannabis in Bermuda depends on not only public approval but also on certain criteria like prescribing guidelines, licensed providers, monitoring, and adherence to the existing drug control legislation.

According to the government of Bermuda’s statement in May 2026, the process of developing a regulated system is ongoing. Another statement issued by the government in July 2026 set up the fourth quarter of 2026 as the deadline for the first implementation of reforms in regard to hemp and medical cannabis.

Stay Updated on Medical Cannabis in Bermuda

Want to understand the latest regulations and patient access options? Follow official updates and consult a qualified healthcare professional before considering medical cannabis treatment.

>>Learn More<<

How Bermuda’s Cannabis Policy Has Developed

Various models of regulation of the cannabis policy in Bermuda have been considered, including patient-centered solutions.

The first such proposal was the Medicinal Cannabis Act 2019, which was presented by the government for consultations in December 2019. This draft act provided for establishment of the regulatory body and the licensing scheme concerning all activities related to medicinal products. In addition, the prescription-based system and pharmacy dispensing were proposed for eligible patients.

Further on, the government considered the possibility of reforms related to the proposed licensing scheme. The possible changes included regulated cultivation, manufacturing, transportation, and other types of activities related to medicinal products.

However, the government decided to pursue a different path and considered the possibilities for developing a broader cannabis policy, including legalization for adult consumption. Nevertheless, such a reform initiative faced constitutional and international legal challenges. As a result, in September 2022, the governor did not give royal assent to the Cannabis Licensing Bill 2022 as presented.

What Are the Government’s Announcements Related to the Medical Use of Cannabis?

On May 15, 2026, the government gave its announcement regarding its strategy in implementing regulations concerning the medical use of cannabis. The cabinet has agreed with the progression of the policy and legislative process that will enhance access to cannabis products for individuals who have genuine medical needs.

The government proposes the following four core principles to underpin its strategy:

• Clinical judgement: Qualified medical practitioners would decide if the use of cannabis is suitable for a particular individual.
• Patient protection: Access to cannabis products should be lawful and medically supervised for those qualified.
• Public safety: The necessary measures would be implemented to reduce risks of misuse and diversion.
• Regulatory consistency: Cannabis medical use would fall into Bermuda’s health and controlled-drug regulations.

The government added that the final legislative framework was still undecided at the time of making the May announcement.

The Ministry of National Security gave its update in July 2026. The ministry reported that drafting instructions have been given to the Attorney-General’s Chambers. In addition, the fourth quarter of 2026 has been selected as the target period for the implementation of hemp and medical cannabis regulations.

How Might the Proposed System for Medical Marijuana Work?

The suggested system by the government has a process where patients can access the approved cannabis products. The exact guidelines are going to be stipulated by the final laws and guidelines.

1. Medical Assessment and Prescription

Medical practitioners who are registered can assess the suitability of using cannabis for medical treatment of the patient.

Medical assessment will look at issues such as the symptoms, past medications, health history of the patient, risks, and alternative medicines. The prescription guidelines will have to be set out.

Not all cannabis products are prescribed as medically acceptable. The product approval process and prescription guidelines are what will dictate whether the product can be supplied legally.

2. Importation and Dispensing from Pharmacies

In the proposed model, licensed pharmacies and certified medical establishments will be allowed to import and distribute eligible medical cannabis products.

The policy does not propose patient-driven unlimited importation of medical cannabis products. Instead, the authorized suppliers will control the chain of delivery according to the regulatory framework.

This approach can provide greater consistency because of defined procedures concerning product handling, transportation, documentation, and monitoring.

3. Quality Assurance and Patient Protection

Quality assurance is an integral part of any well-regulated scheme for medical cannabis products. Patients need quality products that provide clear information about their ingredients, potency, and usage.

Depending on the regulatory structure, there can be different requirements related to product certification, storage, record keeping, inspection, and distribution.

Who Is Eligible for Medical Cannabis Treatment?

The proposed system aims to assist people in need of medical cannabis treatment. Still, the exact criteria for becoming eligible and other regulations will depend on the laws established in Bermuda.

People should not consider themselves eligible for treatment due to the diagnosis they have or the fact that they have received a prescription abroad to get cannabis products.

Those who consider using medical cannabis should keep the following steps in mind first:

• Talk to a registered practitioner regarding their symptoms and possible treatments.
• Inquire if it is feasible to use a cannabis-based product based on the situation.
• Identify which products and prescribing system are available in Bermuda according to its current legislation.
• Understand the process of getting the prescribed product from the legal perspective.
• Study all the professional information about possible side effects and interactions.

All these precautions become particularly crucial considering that the system is still being created. People should consider all the available guidelines now without waiting for changes in legislation.

Importance of International Regulations

The interaction of Bermuda with international drug control regulations has affected the formulation of cannabis policies.

The UN Single Convention on Narcotic Drugs, 1961, allows the use of controlled substances for both medical and scientific purposes in a well-regulated manner. It also outlines the duties relating to the regulation and control of specific drugs.

In its justification of medical cannabis reform, the Bermuda government has referred to these duties. The aim of the government in this regard is to create a legalized means of treatment without risking abuse and illegal distribution.

International regulations are not mere legalities. They have the potential to determine the manner in which goods are imported, the bodies involved in their management, and the regulation of prescription and distribution.

What Bermuda has to do is formulate regulations that can help in meeting the healthcare needs without creating doubts in relation to controlled substances.

Medical Cannabis and Recreational Cannabis

There are clear differences between medical cannabis and recreational cannabis policy, which often means there are differences in the ways they should be regulated.

A medical model is based on treatment decisions, professional evaluations, approved medications, and controlled distribution. Recreational policy is based on the non-medical use of cannabis and can have provisions concerning possession, cultivation, retail sales, and taxes.

The July 2026 ministerial statement makes this clear difference especially noticeable. Hemp and hemp-based products as well as medical cannabis are among the top reform priorities of the government at the moment. The regulated framework for recreational use is a separate project.

Therefore, any reforms related to medical access should not be considered a sign of legalization of recreational cannabis and lifting existing restrictions.

All patients, consumers, and businesses should pay attention to the official announcements, as some reform projects will be implemented faster than others.

Changes that Patients and Businesses Need to Look out for?

In the process of implementing the above system, some changes will need to be considered.

Laws and commencement date: The enacted law and the commencement clauses within it will dictate the date on which these new laws will come into effect.

Prescribing criteria: There will be a need for healthcare practitioners and patients to know the criteria used for prescribing the drug.

Authorized providers: There will be a need for authorized providers to know the rules and regulations to observe.

Product authorization: The rules regarding product quality, eligibility, labeling, and supplies will determine which products will be available.

These considerations will define how the future marijuana for medicinal use framework will be implemented in reality. Until all these are finalized, it will not be wise for anybody to make any assumption.

availability or permission by law.

Frequently Asked Questions

1. Is medical cannabis legal in Bermuda?

Bermuda is developing a regulated framework for medical cannabis. The government has announced plans to allow access through medical supervision, but the proposed framework must go through the legislative process before it becomes operational.

2. When will Bermuda introduce its medical cannabis regulations?

The government identified the fourth quarter of 2026 as the target period for implementing hemp and medical cannabis reforms. The actual start date will depend on the completion and commencement of the relevant laws.

3. Who may qualify for medical cannabis treatment in Bermuda?

The proposed system is intended for patients with genuine medical needs. Registered medical practitioners would assess whether medical cannabis is appropriate. Final eligibility criteria have not yet been confirmed.

4. Will patients need a prescription to access medical cannabis?

Under the proposed model, qualified medical practitioners would assess patients and prescribe approved products when appropriate. The final prescription requirements will be established through the legislation and related guidelines.

5. Can patients import medical cannabis products directly into Bermuda?

The proposed framework indicates that authorized pharmacies and approved medical institutions would manage the importation and distribution of eligible products. Direct patient importation is not part of the proposed model.

6. Will medical cannabis legalization also allow recreational cannabis use?

No. The government has treated medical cannabis and hemp reforms as separate priorities from broader recreational cannabis policy. Medical reform should not be interpreted as recreational legalization.

Conclusion

Bermuda is moving towards regulation in terms of medical marijuana with the aim of enhancing accessibility of the medicine but at the same time, keeping up clinical oversight and public safety.

The government’s announcement made in May 2026 outlined the approach, whereas its statement in July 2026 confirmed that legislation was being drafted and highlighted that the fourth quarter of 2026 would be used as the start date of implementing the new hemp and medical policy.

However, proposals are not the same as adopted and operating regulations. The patients are encouraged to seek consultations with professional medical personnel and find out about existing laws on the matter before taking any action.

The effectiveness of Bermuda’s strategy will depend on creating a reasonable and practical system that will protect the patients’ interests and keep an appropriate oversight over cannabis-related medications.

Sources

1. Medical Cannabis Framework – Government of Bermuda (May 15, 2026)
Covers the proposed framework, patient access, medical supervision, prescribing principles, licensed pharmacies, and patient safety.
Read the official government announcement.

2. Advancing Public Safety Across the Ministry of National Security – Government of Bermuda (July 23, 2026)
Confirms that drafting instructions were issued and identifies Q4 2026 as the target for initial implementation of hemp and medical cannabis reforms.
Read the ministerial statement.

3. Hansard – Bermuda House of Assembly (May 15, 2026)
Official parliamentary record of the Minister’s statement on the proposed medical cannabis framework.
Read the parliamentary record.

4. The Royal Gazette – Move on ‘safe and lawful’ access to medical cannabis (May 15, 2026)
Provides additional reporting on the proposed prescription and pharmacy-distribution model.
Read the news report.

5. BBC Bermuda – Medical cannabis framework still in development (May 15, 2026)
Explains the government’s position and the proposed focus on patient safety and regulatory oversight.
Read the report.